comparemela.com
Home
Live Updates
EXCLISIVE: Ocean Biomedicals JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B - Ocean Biomedical (NASDAQ:OCEA) : comparemela.com
EXCLISIVE: Ocean Biomedical's JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B - Ocean Biomedical (NASDAQ:OCEA)
Ocean Biomedical, Inc.
Related Keywords
Hong Kong ,
New Zealand ,
United States ,
,
Ocean Biomedical Inc ,
Falk Medical Research Trust Transformational Award ,
Virion Therapeutics ,
Sue Currie ,
Chief Scientist ,
Jonathan Kurtis ,
comparemela.com © 2020. All Rights Reserved.